Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste.
作者信息
Gower-Rousseau Corinne, Fumery Mathurin, Pariente Benjamin
机构信息
Public Health, Epidemiology and Medico-economic Unit, Epimad Registry, Lille University Hospital and, Institute for Translational Research in Inflammation INFINITE, U1286 Inserm, Université de Lille, CHU de Lille, Lille, France.
Gastroenterology Unit, EPIMAD Registry, Amiens University Hospital and, PERITOX - UMR-I 01 Unité mixte INERIS Périnatalité & Risques Toxiques, Université Jules Verne Picardie, CHU d'Amiens, Amiens, France.
出版信息
Gastroenterology. 2021 Jan;160(1):473-474. doi: 10.1053/j.gastro.2020.05.013. Epub 2020 May 8.
Abstract
摘要
相似文献
1
Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste.炎症性肠病与新型冠状病毒肺炎大流行：更快行动，勿急行事。
Gastroenterology. 2021 Jan;160(1):473-474. doi: 10.1053/j.gastro.2020.05.013. Epub 2020 May 8.
2
Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.炎症性肠病与 SARS-CoV-2 大流行：现有知识和建议。
Scand J Gastroenterol. 2021 Jun;56(6):656-660. doi: 10.1080/00365521.2021.1902561. Epub 2021 Mar 25.
3
Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic.炎症性肠病患者的管理以及新冠疫情第一波期间的治疗结果
Dig Liver Dis. 2021 Jun;53(6):689-690. doi: 10.1016/j.dld.2021.03.021. Epub 2021 Mar 27.
4
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.COVID-19 大流行期间炎症性肠病患者的实用管理：澳大利亚胃肠病学会炎症性肠病学院专家评论。
Intern Med J. 2020 Jul;50(7):798-804. doi: 10.1111/imj.14889.
5
Low frequency of COVID-19 in inflammatory bowel diseases.炎症性肠病中新冠病毒病的低发病率
Dig Liver Dis. 2020 Nov;52(11):1234-1235. doi: 10.1016/j.dld.2020.06.007. Epub 2020 Jun 13.
6
Psychological Challenges for Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
Psychosom Med. 2021 May 1;83(4):397-398. doi: 10.1097/PSY.0000000000000888.
7
Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic.2019冠状病毒病大流行期间炎症性肠病的治疗决策
Gastroenterology. 2021 Apr;160(5):1883-1884. doi: 10.1053/j.gastro.2020.05.083. Epub 2020 Jun 15.
8
Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".完善埃及的情况：对“新冠疫情期间埃及的炎症性肠病”的回应
Inflamm Bowel Dis. 2021 Mar 15;27(4):e39. doi: 10.1093/ibd/izaa355.
9
Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic.2019冠状病毒病大流行期间炎症性肠病患者的风险与获益平衡
Gastroenterology. 2021 Jan;160(1):472-473. doi: 10.1053/j.gastro.2020.04.075. Epub 2020 May 15.
10
Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").对该信函的评论（完善埃及的情况：对“新冠疫情期间埃及的炎症性肠病”的回应）
Inflamm Bowel Dis. 2021 Apr 15;27(5):e66. doi: 10.1093/ibd/izab009.
引用本文的文献
1
Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence.COVID-19 大流行对炎症性肠病患者的影响：当前证据综述。
World J Gastroenterol. 2021 Jul 7;27(25):3748-3761. doi: 10.3748/wjg.v27.i25.3748.
2
Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain.西班牙马德里单中心研究：炎症性肠病患者中 SARS-CoV-2 感染的发生率、临床特征和演变。
Inflamm Bowel Dis. 2021 Jan 1;27(1):25-33. doi: 10.1093/ibd/izaa221.
本文引用的文献
1
Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD).炎症性肠病的流行病学：来自法国基于人群的注册研究（EPIMAD）的新见解。
Dig Liver Dis. 2013 Feb;45(2):89-94. doi: 10.1016/j.dld.2012.09.005. Epub 2012 Oct 27.
Zotero 插件